Kimberly Jo Tzoumakas Receives Stock Award at Coherus BioSciences Inc (CHRS) — SEC Form 4, Jun 09, 2023
SEC Form 4 · No Market Transaction
Stock Award
Compensation grant — no market purchase or sale.
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Kimberly Jo Tzoumakas CIK 0001766666 |
Director
|
Kimberly Jo Tzoumakas at Coherus BioSciences Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at Coherus BioSciences Inc
| 2024-06-05 | Award | — | View |
| 2022-01-10 | Award | — | View |
| 2021-01-13 | Award | — | View |
Derivative Securities Transactions
| Title | Strike | Date | Type | Shares | Price | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $5.38 | 2023-06-07 | A - Award/Grant | 38,250 A | $0.00 | 2033-06-07 | 38,250 Common Stock | Direct |
Footnotes (1)
- F1
- The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from June 7, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Show more
Related filings at Coherus BioSciences Inc
Institutional Holders
13F holders · Jun 30, 2026
146
institutional managers reporting a position
Largest by reported value
- Timothy G. Youngquist 2020 Irrevocable Trust $18.3M
- Black Rock, Inc. $16.8M
- Vanguard Capital Management Llc $8.33M
5%+ Holders · 13D/G
3 filers
Other insiders at Coherus BioSciences Inc
GET /v1/forms/4/0001610717-23-000119
API docs
View Original SEC Filing